Unicycive Therapeutics, Inc. UNCY Q1 2025 Annual earnings
Reported March 31, 2025 · Before market open
EPS-$0.26Miss by $0.13
EPS estimate-$0.13
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$22.2M
EPS estimate-$0.47
Versus estimates
Diluted EPS
Ask the moment Unicycive Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Unicycive Therapeutics, Inc. report Q1 2025 earnings?
- Unicycive Therapeutics, Inc. (UNCY) reported Q1 2025 earnings on March 31, 2025 before market open.
- What were Unicycive Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Unicycive Therapeutics, Inc. reported eps of $-0.26 for Q1 2025.
- Did Unicycive Therapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.13 by $0.13.
- How did Unicycive Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 3.7% from $-0.27.
- Where can I find Unicycive Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-25-025828) directly on SEC EDGAR. The filing index links above go to sec.gov.